LifeStance Health Group, Inc. (LFST): Price and Financial Metrics
GET POWR RATINGS... FREE!
LFST POWR Grades
- Growth is the dimension where LFST ranks best; there it ranks ahead of 94.75% of US stocks.
- LFST's strongest trending metric is Growth; it's been moving up over the last 177 days.
- LFST ranks lowest in Quality; there it ranks in the 5th percentile.
LFST Stock Summary
- With a one year PEG ratio of 0.54, LIFESTANCE HEALTH GROUP INC is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than only 4.96% of US stocks.
- LIFESTANCE HEALTH GROUP INC's stock had its IPO on June 10, 2021, making it an older stock than just 4.85% of US equities in our set.
- The price/operating cash flow metric for LIFESTANCE HEALTH GROUP INC is higher than 89.86% of stocks in our set with a positive cash flow.
- If you're looking for stocks that are quantitatively similar to LIFESTANCE HEALTH GROUP INC, a group of peers worth examining would be LTH, MYNZ, SOPA, CKX, and PRVA.
- LFST's SEC filings can be seen here. And to visit LIFESTANCE HEALTH GROUP INC's official web site, go to www.lifestance.com.
LFST Valuation Summary
- In comparison to the median Healthcare stock, LFST's EV/EBIT ratio is 193.1% lower, now standing at -8.1.
- LFST's price/earnings ratio has moved up 131.1 over the prior 18 months.
Below are key valuation metrics over time for LFST.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| LFST | 2022-12-02 | 2.6 | 1.4 | -7.8 | -8.1 |
| LFST | 2022-12-01 | 2.5 | 1.4 | -7.5 | -7.9 |
| LFST | 2022-11-30 | 2.3 | 1.2 | -6.9 | -7.3 |
| LFST | 2022-11-29 | 2.1 | 1.1 | -6.3 | -6.7 |
| LFST | 2022-11-28 | 2.2 | 1.2 | -6.4 | -6.8 |
| LFST | 2022-11-25 | 2.3 | 1.3 | -6.9 | -7.3 |
LFST Price Target
For more insight on analysts targets of LFST, see our LFST price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $19.20 | Average Broker Recommendation | 1.58 (Moderate Buy) |
LFST Stock Price Chart Interactive Chart >
LFST Price/Volume Stats
| Current price | $5.52 | 52-week high | $11.25 |
| Prev. close | $5.67 | 52-week low | $4.57 |
| Day low | $5.48 | Volume | 131,860 |
| Day high | $5.70 | Avg. volume | 781,716 |
| 50-day MA | $6.70 | Dividend yield | N/A |
| 200-day MA | $7.43 | Market Cap | 2.08B |
LifeStance Health Group, Inc. (LFST) Company Bio
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. The company offers patients care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was incorporated in 2021 and is based in Scottsdale, Arizona.
Latest LFST News From Around the Web
Below are the latest news stories about LIFESTANCE HEALTH GROUP INC that investors may wish to consider to help them evaluate LFST as an investment opportunity.
Lifestance Health Group (LFST) Gets a Hold from Goldman SachsIn a report released today, Jamie Perse from Goldman Sachs maintained a Hold rating on Lifestance Health Group (LFST - Research Report), with a price target of $8.00. The company's shares opened today at $6.28.According to TipRanks, Perse is an analyst with an average return of -7.8% and a 34.78% success rate. Perse covers the Healthcare sector, focusing on stocks such as Agilon Health, Option Care Health, and Tenet Healthcare.In addition to Goldman Sachs, Lifestance Health Group also received a Hold from J.P. Morgan's Lisa Gill in a report issued on November 9. However, yesterday, Cowen & Co. maintained a Buy rating on Lifestance Health Group (NASDAQ: LFST). |
LifeStance Health Group Third Quarter 2022 Earnings: EPS Beats ExpectationsLifeStance Health Group ( NASDAQ:LFST ) Third Quarter 2022 Results Key Financial Results Revenue: US$217.6m (up 25... |
LifeStance Health Group (LFST) Reports Q3 Loss, Lags Revenue EstimatesLifeStance Health (LFST) delivered earnings and revenue surprises of 26.67% and 0.97%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock? |
LifeStance Reports Third Quarter 2022 ResultsSCOTTSDALE, Ariz., Nov. 08, 2022 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the quarter ended September 30, 2022. (All results compared to prior-year comparative period, unless otherwise noted) Q3 2022 Highlights and FY 2022 Outlook Revenue of $217.6 million increased $43.8 million or 25% compared to revenue of $173.8 millionTotal clinicians of 5,431 up 24%, a net i |
LifeStance Health Appoints J. Michael Bruff as New Business Transformation Officer; David Bourdon as Chief Financial OfficerLifeStance Health (NASDAQ: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced that effective November 10, 2022, J. Michael Bruff, currently Chief Financial Officer, will take on a new role as Business Transformation Officer. David Bourdon will join the company and succeed Bruff as Chief Financial Officer. Both executives will report directly to Ken Burdick, Chairman and Chief Executive Officer, LifeStance. |
LFST Price Returns
| 1-mo | -23.86% |
| 3-mo | -27.46% |
| 6-mo | -22.80% |
| 1-year | -37.20% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -42.02% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...